Nukhet Aykin-Burns
Concepts (358)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 20 | 2024 | 446 | 2.120 |
Why?
| | Sirtuin 3 | 9 | 2025 | 19 | 1.650 |
Why?
| | Oxidative Stress | 24 | 2023 | 819 | 1.610 |
Why?
| | Osteoclasts | 8 | 2024 | 428 | 1.480 |
Why?
| | Antioxidants | 6 | 2023 | 264 | 0.800 |
Why?
| | Bone Resorption | 5 | 2024 | 304 | 0.770 |
Why?
| | Polychlorinated Biphenyls | 2 | 2013 | 36 | 0.700 |
Why?
| | Reactive Oxygen Species | 9 | 2016 | 421 | 0.700 |
Why?
| | Cosmic Radiation | 1 | 2021 | 42 | 0.690 |
Why?
| | Tocotrienols | 2 | 2019 | 37 | 0.680 |
Why?
| | Radiation-Protective Agents | 2 | 2019 | 69 | 0.670 |
Why?
| | Cell Compartmentation | 1 | 2020 | 9 | 0.650 |
Why?
| | Osteogenesis | 3 | 2021 | 374 | 0.650 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 85 | 0.640 |
Why?
| | Animals | 38 | 2025 | 13526 | 0.590 |
Why?
| | Aging | 5 | 2024 | 714 | 0.570 |
Why?
| | Vitamin E | 1 | 2019 | 76 | 0.560 |
Why?
| | Mice | 25 | 2025 | 5982 | 0.550 |
Why?
| | Superoxide Dismutase | 9 | 2023 | 122 | 0.530 |
Why?
| | Linear Energy Transfer | 2 | 2013 | 14 | 0.440 |
Why?
| | Neoplasms | 3 | 2023 | 1334 | 0.430 |
Why?
| | Keratinocytes | 2 | 2013 | 91 | 0.420 |
Why?
| | Radiation Tolerance | 3 | 2013 | 78 | 0.410 |
Why?
| | Cystine | 2 | 2020 | 12 | 0.400 |
Why?
| | Cell Proliferation | 5 | 2014 | 1031 | 0.400 |
Why?
| | Prostate | 1 | 2013 | 118 | 0.390 |
Why?
| | Radiation, Ionizing | 5 | 2022 | 101 | 0.380 |
Why?
| | Air Pollutants | 1 | 2013 | 75 | 0.380 |
Why?
| | Environmental Pollutants | 2 | 2013 | 110 | 0.370 |
Why?
| | Acetylcysteine | 5 | 2016 | 104 | 0.360 |
Why?
| | Epithelial Cells | 1 | 2013 | 218 | 0.360 |
Why?
| | Deoxyglucose | 5 | 2010 | 35 | 0.350 |
Why?
| | Environmental Exposure | 1 | 2013 | 222 | 0.350 |
Why?
| | Oxygen | 3 | 2011 | 338 | 0.330 |
Why?
| | Iron | 3 | 2022 | 130 | 0.320 |
Why?
| | Cell Movement | 1 | 2011 | 279 | 0.310 |
Why?
| | Hydrogen Peroxide | 4 | 2020 | 121 | 0.300 |
Why?
| | Glutathione | 12 | 2016 | 303 | 0.290 |
Why?
| | PC12 Cells | 2 | 2006 | 23 | 0.290 |
Why?
| | Cell Line, Tumor | 9 | 2020 | 1470 | 0.290 |
Why?
| | Fibroblasts | 6 | 2016 | 363 | 0.290 |
Why?
| | Mice, Knockout | 9 | 2025 | 910 | 0.290 |
Why?
| | Membrane Proteins | 1 | 2010 | 333 | 0.280 |
Why?
| | Mitochondrial Proteins | 2 | 2024 | 90 | 0.280 |
Why?
| | Colonic Neoplasms | 2 | 2025 | 162 | 0.280 |
Why?
| | Antineoplastic Agents | 4 | 2023 | 1232 | 0.270 |
Why?
| | Apoptosis | 7 | 2020 | 1139 | 0.260 |
Why?
| | Male | 19 | 2025 | 27435 | 0.250 |
Why?
| | Organoselenium Compounds | 1 | 2006 | 3 | 0.240 |
Why?
| | Fructose | 1 | 2025 | 21 | 0.240 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 21 | 0.240 |
Why?
| | Organometallic Compounds | 1 | 2006 | 42 | 0.230 |
Why?
| | Lead | 1 | 2005 | 33 | 0.230 |
Why?
| | Cell Survival | 7 | 2015 | 600 | 0.230 |
Why?
| | Colon | 1 | 2025 | 106 | 0.230 |
Why?
| | Superoxides | 4 | 2013 | 46 | 0.230 |
Why?
| | Cricetinae | 5 | 2021 | 190 | 0.230 |
Why?
| | Mutation | 1 | 2010 | 1337 | 0.220 |
Why?
| | Carcinogens | 1 | 2025 | 194 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2015 | 1367 | 0.210 |
Why?
| | Osteoporosis | 2 | 2024 | 159 | 0.200 |
Why?
| | Animals, Wild | 1 | 2023 | 10 | 0.200 |
Why?
| | Fertility Preservation | 1 | 2023 | 10 | 0.200 |
Why?
| | Adenosine Triphosphate | 3 | 2020 | 211 | 0.190 |
Why?
| | Oxidation-Reduction | 4 | 2020 | 333 | 0.190 |
Why?
| | Cells, Cultured | 5 | 2020 | 1569 | 0.190 |
Why?
| | Glutathione Disulfide | 6 | 2011 | 38 | 0.190 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2020 | 62 | 0.190 |
Why?
| | Rats | 8 | 2021 | 3162 | 0.190 |
Why?
| | Receptors, Transferrin | 1 | 2022 | 16 | 0.190 |
Why?
| | Oxidative Phosphorylation | 2 | 2020 | 48 | 0.180 |
Why?
| | Estrogens | 2 | 2021 | 224 | 0.180 |
Why?
| | Humans | 26 | 2025 | 53230 | 0.180 |
Why?
| | Carrier Proteins | 2 | 2014 | 315 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2022 | 202 | 0.180 |
Why?
| | Protein C | 1 | 2021 | 20 | 0.170 |
Why?
| | Catalase | 7 | 2016 | 72 | 0.170 |
Why?
| | Female | 16 | 2024 | 28782 | 0.170 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 1925 | 0.170 |
Why?
| | Hippocampus | 1 | 2023 | 195 | 0.170 |
Why?
| | Mice, Inbred BALB C | 1 | 2021 | 310 | 0.170 |
Why?
| | Cell Line | 5 | 2015 | 1016 | 0.170 |
Why?
| | Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.160 |
Why?
| | Intestine, Small | 1 | 2021 | 114 | 0.160 |
Why?
| | Transduction, Genetic | 1 | 2020 | 44 | 0.160 |
Why?
| | Subcellular Fractions | 1 | 2020 | 33 | 0.160 |
Why?
| | Cricetulus | 3 | 2010 | 101 | 0.160 |
Why?
| | Cytosol | 1 | 2020 | 80 | 0.160 |
Why?
| | Cysteine | 1 | 2020 | 50 | 0.160 |
Why?
| | Biosensing Techniques | 1 | 2020 | 32 | 0.160 |
Why?
| | Neoplasms, Experimental | 1 | 2020 | 112 | 0.160 |
Why?
| | Cognition | 1 | 2023 | 346 | 0.160 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 89 | 0.160 |
Why?
| | Microscopy, Fluorescence | 1 | 2020 | 140 | 0.160 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2011 | 187 | 0.150 |
Why?
| | Signal Transduction | 6 | 2025 | 1748 | 0.150 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2020 | 235 | 0.150 |
Why?
| | Disease Models, Animal | 2 | 2023 | 1517 | 0.140 |
Why?
| | Time Factors | 6 | 2016 | 2991 | 0.140 |
Why?
| | Cation Transport Proteins | 1 | 2018 | 26 | 0.140 |
Why?
| | Skin | 1 | 2021 | 419 | 0.140 |
Why?
| | Myeloid Cells | 1 | 2018 | 45 | 0.140 |
Why?
| | Breast Neoplasms | 4 | 2014 | 1222 | 0.140 |
Why?
| | Models, Biological | 5 | 2014 | 737 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2011 | 228 | 0.130 |
Why?
| | Buthionine Sulfoximine | 4 | 2016 | 13 | 0.130 |
Why?
| | MicroRNAs | 1 | 2021 | 397 | 0.130 |
Why?
| | Peroxynitrous Acid | 2 | 2014 | 33 | 0.130 |
Why?
| | Heart | 2 | 2021 | 350 | 0.130 |
Why?
| | Malondialdehyde | 3 | 2006 | 55 | 0.130 |
Why?
| | Gene Deletion | 1 | 2018 | 279 | 0.130 |
Why?
| | Radiation Injuries, Experimental | 2 | 2015 | 80 | 0.130 |
Why?
| | Genetic Therapy | 2 | 2007 | 127 | 0.130 |
Why?
| | bcl-2-Associated X Protein | 2 | 2014 | 58 | 0.120 |
Why?
| | Whole-Body Irradiation | 2 | 2015 | 129 | 0.120 |
Why?
| | RNA, Messenger | 3 | 2015 | 1133 | 0.120 |
Why?
| | Thrombomodulin | 1 | 2016 | 26 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-delta | 1 | 2016 | 23 | 0.120 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 412 | 0.120 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2016 | 76 | 0.120 |
Why?
| | Peptides | 2 | 2014 | 234 | 0.120 |
Why?
| | Myoblasts | 1 | 2015 | 19 | 0.120 |
Why?
| | DNA Damage | 3 | 2015 | 309 | 0.120 |
Why?
| | Guanidines | 1 | 2015 | 28 | 0.120 |
Why?
| | Aniline Compounds | 1 | 2015 | 48 | 0.110 |
Why?
| | Particulate Matter | 1 | 2015 | 66 | 0.110 |
Why?
| | Intestines | 1 | 2016 | 159 | 0.110 |
Why?
| | Enzyme Inhibitors | 2 | 2015 | 371 | 0.110 |
Why?
| | Recombinant Proteins | 1 | 2016 | 489 | 0.110 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 39 | 0.110 |
Why?
| | Sulfonamides | 1 | 2015 | 139 | 0.110 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2015 | 120 | 0.110 |
Why?
| | Blotting, Western | 6 | 2015 | 587 | 0.110 |
Why?
| | Hepatocytes | 1 | 2015 | 188 | 0.110 |
Why?
| | Gene Expression Regulation | 4 | 2021 | 1003 | 0.110 |
Why?
| | beta Catenin | 1 | 2014 | 107 | 0.100 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 189 | 0.100 |
Why?
| | Chromosome Aberrations | 1 | 2015 | 297 | 0.100 |
Why?
| | Wnt Signaling Pathway | 1 | 2014 | 98 | 0.100 |
Why?
| | Cytoprotection | 1 | 2013 | 32 | 0.100 |
Why?
| | Hydroxylation | 1 | 2013 | 64 | 0.100 |
Why?
| | Selenoprotein P | 1 | 2013 | 1 | 0.100 |
Why?
| | Biotransformation | 1 | 2013 | 84 | 0.100 |
Why?
| | Heavy Ions | 1 | 2013 | 15 | 0.100 |
Why?
| | Thymus Neoplasms | 1 | 2013 | 15 | 0.100 |
Why?
| | Benzoquinones | 1 | 2013 | 33 | 0.100 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2013 | 37 | 0.100 |
Why?
| | Metabolome | 1 | 2014 | 107 | 0.100 |
Why?
| | Cell Respiration | 3 | 2022 | 49 | 0.100 |
Why?
| | DNA | 1 | 2016 | 535 | 0.100 |
Why?
| | Genomic Instability | 2 | 2011 | 88 | 0.100 |
Why?
| | Acetaminophen | 1 | 2015 | 277 | 0.100 |
Why?
| | Lymphoma | 1 | 2013 | 71 | 0.090 |
Why?
| | Macrophages | 1 | 2015 | 380 | 0.090 |
Why?
| | Lipid Peroxidation | 3 | 2014 | 98 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2015 | 333 | 0.090 |
Why?
| | Rotenone | 2 | 2009 | 13 | 0.090 |
Why?
| | Succinate Dehydrogenase | 1 | 2011 | 22 | 0.090 |
Why?
| | Sex Characteristics | 1 | 2013 | 204 | 0.090 |
Why?
| | Antimetabolites | 2 | 2010 | 12 | 0.090 |
Why?
| | Liver Cirrhosis | 1 | 2014 | 246 | 0.090 |
Why?
| | Protein Subunits | 1 | 2011 | 77 | 0.090 |
Why?
| | DNA Methylation | 1 | 2015 | 592 | 0.090 |
Why?
| | Dyskeratosis Congenita | 1 | 2011 | 2 | 0.090 |
Why?
| | Immunoblotting | 3 | 2021 | 118 | 0.090 |
Why?
| | Myocardium | 1 | 2014 | 471 | 0.080 |
Why?
| | Telomerase | 1 | 2011 | 26 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 68 | 0.080 |
Why?
| | Gene Expression | 5 | 2013 | 618 | 0.080 |
Why?
| | Electron Transport Complex II | 1 | 2009 | 7 | 0.080 |
Why?
| | CHO Cells | 2 | 2009 | 124 | 0.080 |
Why?
| | Genes, Tumor Suppressor | 1 | 2010 | 73 | 0.080 |
Why?
| | Glutathione Peroxidase | 2 | 2007 | 23 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2021 | 3494 | 0.070 |
Why?
| | Kidney | 1 | 2014 | 715 | 0.070 |
Why?
| | Wound Healing | 1 | 2011 | 226 | 0.070 |
Why?
| | Membrane Potential, Mitochondrial | 3 | 2015 | 44 | 0.070 |
Why?
| | Adult | 3 | 2021 | 14534 | 0.070 |
Why?
| | Zidovudine | 1 | 2008 | 7 | 0.070 |
Why?
| | Werner Syndrome | 1 | 2008 | 14 | 0.070 |
Why?
| | Exodeoxyribonucleases | 1 | 2008 | 21 | 0.070 |
Why?
| | RecQ Helicases | 1 | 2008 | 22 | 0.070 |
Why?
| | Cell Differentiation | 2 | 2022 | 681 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2010 | 184 | 0.070 |
Why?
| | Sirtuins | 1 | 2008 | 12 | 0.070 |
Why?
| | Polyethylene Glycols | 3 | 2016 | 95 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 16 | 0.070 |
Why?
| | Liver | 1 | 2014 | 1150 | 0.070 |
Why?
| | Tobacco Smoke Pollution | 1 | 2008 | 56 | 0.070 |
Why?
| | Glucose | 2 | 2007 | 361 | 0.070 |
Why?
| | Carmustine | 1 | 2007 | 12 | 0.070 |
Why?
| | Immunohistochemistry | 3 | 2021 | 975 | 0.070 |
Why?
| | Adenoviridae | 1 | 2007 | 46 | 0.070 |
Why?
| | Forkhead Transcription Factors | 1 | 2008 | 120 | 0.070 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2007 | 78 | 0.070 |
Why?
| | Radiation-Sensitizing Agents | 1 | 2007 | 50 | 0.070 |
Why?
| | Antiviral Agents | 2 | 2021 | 179 | 0.070 |
Why?
| | Methionine | 1 | 2008 | 142 | 0.060 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 147 | 0.060 |
Why?
| | Cisplatin | 1 | 2008 | 282 | 0.060 |
Why?
| | Neurites | 1 | 2006 | 13 | 0.060 |
Why?
| | Glutamate-Cysteine Ligase | 1 | 2006 | 20 | 0.060 |
Why?
| | Caspase 3 | 1 | 2006 | 92 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2006 | 68 | 0.060 |
Why?
| | Trypan Blue | 1 | 2005 | 4 | 0.060 |
Why?
| | Caspases | 1 | 2006 | 101 | 0.060 |
Why?
| | Heart Diseases | 1 | 2008 | 221 | 0.060 |
Why?
| | Head and Neck Neoplasms | 1 | 2008 | 291 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 2007 | 219 | 0.060 |
Why?
| | Drug Combinations | 1 | 2005 | 138 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2015 | 109 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2016 | 187 | 0.050 |
Why?
| | Transfection | 3 | 2011 | 359 | 0.050 |
Why?
| | Acetylation | 1 | 2024 | 97 | 0.050 |
Why?
| | Prostatic Neoplasms | 1 | 2007 | 401 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 128 | 0.050 |
Why?
| | Protein Kinases | 1 | 2024 | 72 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 1043 | 0.050 |
Why?
| | Middle Aged | 2 | 2021 | 13419 | 0.050 |
Why?
| | Aged | 2 | 2021 | 10429 | 0.050 |
Why?
| | Ovary | 1 | 2023 | 103 | 0.050 |
Why?
| | Reproduction | 1 | 2023 | 64 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2022 | 69 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2015 | 180 | 0.050 |
Why?
| | Cytoskeleton | 1 | 2022 | 39 | 0.050 |
Why?
| | Phenylketonurias | 1 | 2002 | 12 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2014 | 561 | 0.050 |
Why?
| | Ferrets | 1 | 2021 | 7 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 1544 | 0.040 |
Why?
| | Diet | 1 | 2025 | 610 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 76 | 0.040 |
Why?
| | NADP | 3 | 2007 | 23 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 246 | 0.040 |
Why?
| | Young Adult | 1 | 2011 | 4511 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 141 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 97 | 0.040 |
Why?
| | Genotype | 1 | 2021 | 563 | 0.040 |
Why?
| | Heart Rate | 1 | 2021 | 314 | 0.040 |
Why?
| | Free Radical Scavengers | 2 | 2010 | 24 | 0.040 |
Why?
| | Protein Binding | 2 | 2013 | 670 | 0.040 |
Why?
| | HCT116 Cells | 2 | 2009 | 31 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2013 | 400 | 0.040 |
Why?
| | Proteomics | 1 | 2021 | 336 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 274 | 0.040 |
Why?
| | Sulfhydryl Compounds | 2 | 2008 | 17 | 0.040 |
Why?
| | Mice, Nude | 2 | 2009 | 232 | 0.030 |
Why?
| | Bone Density | 1 | 2020 | 397 | 0.030 |
Why?
| | Osteoblasts | 1 | 2021 | 480 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2022 | 610 | 0.030 |
Why?
| | Antimycin A | 2 | 2009 | 6 | 0.030 |
Why?
| | Drug Synergism | 2 | 2009 | 147 | 0.030 |
Why?
| | Electron Transport | 2 | 2009 | 24 | 0.030 |
Why?
| | Inflammation | 1 | 2021 | 652 | 0.030 |
Why?
| | Tumor Cells, Cultured | 2 | 2007 | 441 | 0.030 |
Why?
| | Peroxidase | 1 | 2016 | 18 | 0.030 |
Why?
| | Glutathione Reductase | 2 | 2007 | 14 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2016 | 25 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2016 | 71 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2016 | 62 | 0.030 |
Why?
| | Bone and Bones | 1 | 2020 | 501 | 0.030 |
Why?
| | Gamma Rays | 1 | 2016 | 48 | 0.030 |
Why?
| | Aldehydes | 1 | 2016 | 81 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2015 | 22 | 0.030 |
Why?
| | Rejuvenation | 1 | 2015 | 7 | 0.030 |
Why?
| | Ganciclovir | 1 | 2015 | 23 | 0.030 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2015 | 10 | 0.030 |
Why?
| | DNA, Satellite | 1 | 2015 | 10 | 0.030 |
Why?
| | Microscopy | 1 | 2015 | 47 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2007 | 640 | 0.030 |
Why?
| | Reactive Nitrogen Species | 1 | 2015 | 23 | 0.030 |
Why?
| | NAD | 1 | 2015 | 45 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2016 | 136 | 0.030 |
Why?
| | bcl-X Protein | 1 | 2015 | 56 | 0.030 |
Why?
| | Mitochondria, Liver | 1 | 2015 | 69 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 2015 | 107 | 0.030 |
Why?
| | X-Rays | 1 | 2015 | 55 | 0.030 |
Why?
| | Collagen | 1 | 2016 | 215 | 0.030 |
Why?
| | Epigenomics | 1 | 2015 | 76 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2016 | 229 | 0.030 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2014 | 6 | 0.030 |
Why?
| | Cell Cycle | 1 | 2015 | 237 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2015 | 178 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2015 | 201 | 0.030 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2014 | 18 | 0.030 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2014 | 11 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2014 | 10 | 0.030 |
Why?
| | Ubiquinone | 1 | 2014 | 14 | 0.030 |
Why?
| | Organophosphorus Compounds | 1 | 2014 | 18 | 0.030 |
Why?
| | Thymocytes | 1 | 2013 | 1 | 0.030 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2013 | 2 | 0.030 |
Why?
| | Cesium Radioisotopes | 1 | 2013 | 4 | 0.030 |
Why?
| | Silicon | 1 | 2013 | 9 | 0.030 |
Why?
| | Protein Conformation | 1 | 2014 | 174 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2013 | 69 | 0.030 |
Why?
| | Gene Order | 1 | 2013 | 13 | 0.030 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2013 | 18 | 0.020 |
Why?
| | Gene Dosage | 1 | 2013 | 76 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2013 | 71 | 0.020 |
Why?
| | Gene Targeting | 1 | 2013 | 28 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2014 | 189 | 0.020 |
Why?
| | DNA, Mitochondrial | 1 | 2014 | 116 | 0.020 |
Why?
| | Metabolomics | 1 | 2014 | 155 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 181 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2013 | 175 | 0.020 |
Why?
| | Radiation Dosage | 1 | 2013 | 160 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 456 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 412 | 0.020 |
Why?
| | Mutation Rate | 1 | 2011 | 36 | 0.020 |
Why?
| | Point Mutation | 1 | 2011 | 67 | 0.020 |
Why?
| | Plasmids | 1 | 2011 | 164 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 868 | 0.020 |
Why?
| | Transglutaminases | 1 | 2010 | 14 | 0.020 |
Why?
| | Tubulin | 1 | 2010 | 22 | 0.020 |
Why?
| | Neuroblastoma | 1 | 2010 | 55 | 0.020 |
Why?
| | GTP-Binding Proteins | 1 | 2010 | 85 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 815 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 93 | 0.020 |
Why?
| | Glycoproteins | 1 | 2010 | 121 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 452 | 0.020 |
Why?
| | Uncoupling Agents | 1 | 2009 | 5 | 0.020 |
Why?
| | HT29 Cells | 1 | 2009 | 13 | 0.020 |
Why?
| | Tumor Burden | 1 | 2009 | 132 | 0.020 |
Why?
| | Antigens, CD | 1 | 2010 | 217 | 0.020 |
Why?
| | Stem Cells | 1 | 2010 | 189 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2009 | 228 | 0.020 |
Why?
| | COS Cells | 1 | 2008 | 74 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2008 | 48 | 0.020 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2008 | 2 | 0.020 |
Why?
| | Calmodulin | 1 | 2008 | 10 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2008 | 99 | 0.020 |
Why?
| | Oxidoreductases | 1 | 2008 | 57 | 0.020 |
Why?
| | Tumor Stem Cell Assay | 1 | 2007 | 16 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2007 | 78 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2008 | 140 | 0.020 |
Why?
| | Down-Regulation | 1 | 2008 | 344 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2007 | 163 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 579 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2008 | 405 | 0.020 |
Why?
| | Neurons | 1 | 2010 | 394 | 0.020 |
Why?
| | Angiotensin II | 1 | 2008 | 161 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2008 | 250 | 0.020 |
Why?
| | Calcium | 1 | 2008 | 373 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2008 | 330 | 0.020 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2006 | 39 | 0.010 |
Why?
| | Lung | 1 | 2008 | 481 | 0.010 |
Why?
| | Methacrylates | 1 | 2004 | 6 | 0.010 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2004 | 10 | 0.010 |
Why?
| | Free Radicals | 1 | 2004 | 27 | 0.010 |
Why?
| | Electrons | 1 | 2004 | 20 | 0.010 |
Why?
| | Oxidants | 1 | 2004 | 51 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 2004 | 73 | 0.010 |
Why?
| | Manganese | 1 | 2004 | 22 | 0.010 |
Why?
| | Thiazoles | 1 | 2004 | 52 | 0.010 |
Why?
| | Osteosarcoma | 1 | 2004 | 44 | 0.010 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2002 | 5 | 0.010 |
Why?
| | Erythrocytes | 1 | 2002 | 70 | 0.010 |
Why?
| | Phenylalanine | 1 | 2002 | 136 | 0.010 |
Why?
| | Brain | 1 | 2002 | 1350 | 0.010 |
Why?
|
|
Aykin-Burns's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|